Rankings / Immune & Inflammation
Systemic glucocorticoids (prednisone / dexamethasone / triamcinolone)
Immune & Inflammation · Glucocorticoid / anti-inflammatory steroid
Tier C-
High-risk evidence profile
Bottom line
Read Off Label grades Systemic glucocorticoids (prednisone / dexamethasone / triamcinolone) as C- (4.3/10) based on moderate evidence, med benefit magnitude, and a high-risk safety profile.
Its high-risk evidence profile reflects a Safety score of 2/10; reported benefits and harms can differ by indication, dose, route, duration, and population.
WADA coverage: beclometasone, betamethasone, budesonide, ciclesonide, cortisone, deflazacort, dexamethasone, flunisolide, fluocortolone, fluticasone, hydrocortisone, methylprednisolone, mometasone, prednisolone, prednisone and triamcinolone acetonide.
Studied, labeled, or reported-use context: Clinical dosing varies by drug/indication; no performance dose — Rx; WADA S9 prohibited in competition by oral, rectal, injectable or other systemic routes; not individualized guidance.
What the evidence says
WADA coverage: beclometasone, betamethasone, budesonide, ciclesonide, cortisone, deflazacort, dexamethasone, flunisolide, fluocortolone, fluticasone, hydrocortisone, methylprednisolone, mometasone, prednisolone, prednisone and triamcinolone acetonide. Local permitted-route rules are route/time dependent; this row concerns systemic enhancement/recovery use.
Mechanism
Systemic glucocorticoids suppress inflammation and can acutely change pain, energy and recovery perception; chronic or repeated use carries major metabolic and immune costs.
Studied, labeled, or reported dose & route
Clinical dosing varies by drug/indication; no performance dose
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Systemic glucocorticoids (prednisone / dexamethasone / triamcinolone)'s effects?
- Read Off Label rates the evidence for Systemic glucocorticoids (prednisone / dexamethasone / triamcinolone) as Moderate and the benefit magnitude as med, producing an overall grade of C- (4.3/10). WADA coverage: beclometasone, betamethasone, budesonide, ciclesonide, cortisone, deflazacort, dexamethasone, flunisolide, fluocortolone, fluticasone, hydrocortisone, methylprednisolone, mometasone, prednisolone, prednisone and triamcinolone acetonide.
- What safety findings are reported for Systemic glucocorticoids (prednisone / dexamethasone / triamcinolone)?
- Systemic glucocorticoids (prednisone / dexamethasone / triamcinolone) has a high risk profile in the database. High (hyperglycemia, hypertension, infection risk, mood/insomnia, bone loss, adrenal suppression, muscle wasting with chronic use) Legal status: Rx; WADA S9 prohibited in competition by oral, rectal, injectable or other systemic routes.
- What does the low Safety score for Systemic glucocorticoids (prednisone / dexamethasone / triamcinolone) represent?
- The Safety score is 2/10. It records the substantial harms described for one or more use contexts; the Benefit score, indication, dose, route, duration, population, and legal status remain separate parts of the evidence profile.
- What doses or routes are reported for Systemic glucocorticoids (prednisone / dexamethasone / triamcinolone)?
- Clinical dosing varies by drug/indication; no performance dose This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Systemic glucocorticoids (prednisone / dexamethasone / triamcinolone) work?
- Systemic glucocorticoids suppress inflammation and can acutely change pain, energy and recovery perception; chronic or repeated use carries major metabolic and immune costs.
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.